肿瘤微环境
免疫抑制
免疫系统
癌症研究
头颈部鳞状细胞癌
淋巴结
生物
免疫学
医学
癌症
头颈部癌
内科学
作者
Tingwei Lu,Zhen Zhang,Jianjun Zhang,Xinhua Pan,Xueqiong Zhu,Xu Wang,Zhihui Li,Min Ruan,Huasheng Li,Wantao Chen,Ming Yan
摘要
Research on tumour cell-derived small extracellular vesicles (sEVs) that regulate tumour microenvironment (TME) has provided strategies for targeted therapy of head and neck squamous cell carcinoma (HNSCC). Herein, we demonstrated that sEVs derived from HNSCC cancer cells carried CD73 (sEVsCD73 ), which promoted malignant progression and mediated immune evasion. The sEVsCD73 phagocytosed by tumour-associated macrophages (TAMs) in the TME induced immunosuppression. Higher CD73high TAMs infiltration levels in the HNSCC microenvironment were correlated with poorer prognosis, while sEVsCD73 activated the NF-κB pathway in TAMs, thereby inhibiting immune function by increasing cytokines secretion such as IL-6, IL-10, TNF-α, and TGF-β1. The absence of sEVsCD73 enhanced the sensitivity of anti-PD-1 therapy through reversed immunosuppression. Moreover, circulating sEVsCD73 increased the risk of lymph node metastasis and worse prognosis. Taken together, our study suggests that sEVsCD73 derived from tumour cells contributes to immunosuppression and is a potential predictor of anti-PD-1 responses for immune checkpoint therapy in HNSCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI